tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Regeneron price target raised to $865 from $750 at Oppenheimer
PremiumThe FlyRegeneron price target raised to $865 from $750 at Oppenheimer
13d ago
Regeneron announces upcoming presentations at Angiogenesis annual meeting
Premium
The Fly
Regeneron announces upcoming presentations at Angiogenesis annual meeting
13d ago
Regeneron price target raised to $950 from $850 at JPMorgan
Premium
The Fly
Regeneron price target raised to $950 from $850 at JPMorgan
13d ago
Regeneron Pharmaceuticals: Robust 4Q25 Beat, Underappreciated Pipeline Upside, and 2026 Catalysts Support Buy Rating and $870 Target
PremiumRatingsRegeneron Pharmaceuticals: Robust 4Q25 Beat, Underappreciated Pipeline Upside, and 2026 Catalysts Support Buy Rating and $870 Target
16d ago
Regeneron price target raised to $870 from $820 at Raymond James
Premium
The Fly
Regeneron price target raised to $870 from $820 at Raymond James
16d ago
Regeneron reports Q4 non-GAAP EPS $11.44, consensus $10.74
Premium
The Fly
Regeneron reports Q4 non-GAAP EPS $11.44, consensus $10.74
16d ago
Regeneron price target raised to $916 from $911 at Bernstein
PremiumThe FlyRegeneron price target raised to $916 from $911 at Bernstein
19d ago
Regeneron: Dupixent-Led Growth, EYLEA Franchise Stabilization, and High-Value Pipeline Catalysts Underpin Buy Rating
Premium
Ratings
Regeneron: Dupixent-Led Growth, EYLEA Franchise Stabilization, and High-Value Pipeline Catalysts Underpin Buy Rating
20d ago
Regeneron price target raised to $875 from $750 at Evercore ISI
Premium
The Fly
Regeneron price target raised to $875 from $750 at Evercore ISI
24d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100